Epidemiologic features of pain in pediatric cancer patients: a co-operative community-based study. North Central Cancer Treatment Group and Mayo Clinic).
The prevalence, etiology, and management of pain in pediatric cancer patients seen at the Mayo Clinic and member institutions of the North Central Cancer Treatment Group were assessed. Participating centers, including both primary care and referral institutions, surveyed all patients seen during a 1-week period (Monday through Friday); procedure-related pain was excluded. Of the 160 children surveyed, 28 reported pain of which 57.8% was related to a side effect of anticancer treatment, 21.1% was unrelated to the malignancy, and 21.1% arose directly from the cancer. Pain intensity assessment was performed by both health-care professional and patient using a variety of measurement tools. Correlation between assessors was close except in young children. The predominance of treatment-related rather than cancer-related pain differs from results in series in adult cancer patients.
Elliott
S C
SC
Iowa Oncology Research Association CCOP, Des Moines.
Miser
A W
AW
Dose
A M
AM
Betcher
D L
DL
O'Fallon
J R
JR
Ducos
R S
RS
Shah
N R
NR
Goh
T S
TS
Monzon
C M
CM
Tschetter
L
L
D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D009369:Neoplasms / Q000188:drug therapy / Q000503:physiopathology*; D010147:Pain Measurement; D010148:Intractable Pain / Q000453:epidemiology* / Q000209:etiology / Q000523:psychology
D000970:Antineoplastic Agents